NCT01029366 2023-06-22
CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy
University of Pennsylvania
Phase 1 Completed
Clinical Trials
1 trialsLeukemia, Prolymphocytic × CTL019 chimeric antigen receptor × Other hematologic neoplasm × Clear all